PREVIOUS MEETINGS
1 LUNG CONTUSION
2 THE ROLE OF INTRAMEDULLARY PRESSURE CHANGES. HYPOVOLEMIA AND ENDOTOXEMIA IN A SHEEP LUNG MODEL
3 NEUTROPHILS MEDIATE REMOTE INJURY FOLLOWING ISCHEMIA
4 EPITHELIAL NEUTROPHIL ACTIVATING PROTEIN (ENA-78) MEDIATES HEPATIC ISCHEMIA-REPERFUSION (I/R) INDUCED LIVER AND LUNG INJURY
5 LUNG-DERIVED TNFα TRIGGERS MULTI-CYTOKINE PRODUCTION IN ARDS
6 ENDOTOXIN PRIMES PMN FOR IL-8-INDUCED OXIDATIVE METABOLISM WITH COORDINATED RECEPTOR RELOCATION
7 DIRECT INJURY OF THE LUNG
8 EARLY SPIRAL CHEST CT-SCAN. LUNG CONTUSION AND POSTTRAUMATIC INFLAMMATORY RESPONSE
9 INTRAMEDULLARY PRESSURE, BONE MARROW FAT RELEASE AND PMN-ELASTASE LIBERATION IN UNREAMED FEMORAL NAILING
10 ENHANCED TRAUMA MEDIATOR CONCENTRATION IN FEMORAL VEIN AFTER TIBIAL NAILING - INFLUENCE OF OSTEOSYNTHESIS TECHNIQUE AND SOFT TISSUE DAMAGE
11 PULMONARY COMPLICATIONS OF FEMORAL FRACTURE
12 SEPSIS AND THE ADULT RESPIRATORY DISTRESS SYNDROME (ARDS)
13 BLOOD CELL DERIVED MEDIATORS INDUCE LUNG EDEMA-STUDIES ON ISOLATED PERFUSED RABBIT LUNGS
14 PATHOPHYSIOLOGY OF SEPTIC INDUCED PULMONARY CAPILLARY PERMEABILITY EDEMA
15 STRATEGIES OF MASSIVE TRANSFUSION AND GOAL DIRECTED RESPIRATORY SUPPORT
16 PRONE POSITION IN TRAUMA PATIENTS WITH ARDS
17 PRONE POSITION IN THE TREATMENT OF ARDS OF NON-TRAUMATIC ORIGIN
18 NITRIC OXIDE (NO) VERSUS EXTRA CORPOREAL LUNG SUPPORT (ECLS) IN ACUTE LUNG FAILURE
19 INHALED NO AND AEROSOLIZED PGI2 IN SEPTIC SHOCK-DIFFERENTIALEFFECTS ON SPLANCHNIC OXYGENATION?
20 THE PROTECTIVE ROLE OF THE GLUTATHIONE (GSH) AND N-ACETYLCYSTEINE (NAC) BY AEROSOL ADMINISTRATION IN THE A.R.D.S
21 MEMBRANE SURFACE AREA REQUIREMENTS FOR AN INTRAVENACAVAL GAS EXCHANGE DEVICE (IVOX) TO ACHIEVE SIGNIFICANT CO2 REMOVAL
22 ANTI ADHERENCE MEASURES IN EXPERIMENTAL LUNG INJURY
23 PULMONARY DYSFUNCTION IN CHRONIC ENDOTOXEMIA AND BACTEREMIA AND NITRIC OXIDE SYNTHASE INHIBITION
24 SURFACTANT DISTURBANCES IN ARDS
25 RATIONAL CONCEPTS FOR THE APPLICATION OF EXOGENOUS SURFACTANT
26 RATIONALE AND TECHNIQUES TO IMPROVE VENTILATION AND GAS EXCHANGE IN ACUTE LUNG INJURY
27 TNF GENERATION IN AN ISOLATED PERFUSED RABBIT LUNG
28 DIFFERENT PATHOPHYSIOLOGICAL MECHANISMS OF BRADYKININ, HISTAMINE AND SEROTONIN ON LUNG BARRIER FUNCTION
29 A NOVEL PANCREATITIS ASSOCIATED PROTEIN
30 ROLE OF INHIBITION OF FIBRINO(GENO)LYSIS IN THROMBIN-INDUCED ACUTE LUNG INJURY IN RATS
31 SURFACTANT AS A CARRIER FOR ANTIBIOTICS
32 RAPID INDUCTION OF PROCOAGULATORY ACTIVITY IN A BABOON MODEL OF RESPIRATORY FAILURE
33 CHANGES OF SURFACTANT IN VITRO FUNCTION IN A LONG TERM LUNG INJURY MODEL
34 GUTPERMEABILITY AND TRANSLOCATION
35 SIGNIFICANCE OF TRANSLOCATION IN THE DEVELOPMENT OF ORGAN INJURY
36 COMPLEMENT MEDIATION OF LOCAL ISCHEMIC INJURY
37 THE ROLE OF THE GUT IN SEVERE ACUTE PANCREATITIS
38 ECOLOGICAL CHANGE OF INTESTINAL FLORA AND ENDOTOXIN/BACTERIAL TRANSLOCATION IN RABBITS AFTER HEMORRHAGIC SHOCK
39 HETEROGENEITY OF HEPATIC RESPONSE TO ISCHEMIA OR INFLAMMATION
40 HEPATIC CHANGES AFTER HEMORRHAGIC SHOCK
41 MECHANISMS OF ALTERED HEPATOCYTE Ca2+-HOMEOSTAS1S DURING HEMORRHAGE AND RESUSCITATION
42 THE LIVER AS AH IMMUNOLOGIC ORGAN IN TRAUMA AND SEPSIS
43 LIVER-LUNG INTERACTIONS DURING GRAM-NEGATIVE BACTEREMIA
44 INFLUENCE OF LOCAL AND SYSTEMIC INSULTS ON BACTERIAL CLEARANCE, KILLING AND DISSEMINATION
45 PATTERN OF INTESTINAL PERMEABILITY CHANGES AND INFLAMMATORY RESPONSE IN POLYTRAUMA PATIENTS
46 TRANSLOCATION OF BACTERIA AND ENDOTOXIN FROM THE INTESTINAL TRACT
47 PATTERNS OF ENDOTOXIN AND CYTOKINES IN POLYTRAUMA PATIENTS - EARLY INDICATORS OF MOF?
48 BACTERIAL TRANSLOCATION (BT) IS CLINICALLY IRRELEVANT - A TRAUMA SURGEON'S PERSPECTIVE
49 ISCHEMIA AND ENDOTOXIN MEDIATED INFLAMMATORY RESPONSE (TNF, 1L-6, IL-10, TNF RI+II) IN AORTIC ANEURYSM REPAIR
50 ORGAN DYSFUNCTION SCORES
51 RECENT ADVANCES IN GASTRIC TONOMETRY
52 LIVER FUNCTION TESTS
53 MONOETHYLGLYCINEXYLIDIDE (MEGX) FORMATION IN SEPTIC SHOCK
54 SELECTIVE GUT DECONTAMINATION IN MULTIPLE TRAUMA PATIENTS
55 VASOACTIVE DRUGS AND SPLANCHNIC PERFUSION
56 EFFECTS OF DIFFERENT THERAPEUTIC AGENTS ON BACTERIAL TRANSLOCATION AND GUT MORPHOLOGY AFTER HEMORRHAGIC SHOCK AND REPER-FUSION
57 EFFECT OF IVIG ON THE HEPATIC MICRO-VASCULAR RESPONSE TO SEPSIS
58 APOPTOSIS INCREASES BEFORE MUCOSAL NECROSIS AND SHOCK IN THE INTESTINAL REPERFUSION INJURY
59 THE RELATIONSHIP OF ISCHEMIA- AND REPERFUSION-INDUCED MUCOSAL LESIONS FOLLOWING COMPLETE ARTERIAL OCCLUSION IN THE SMALL INTESTINE
60 KINETICS OF PLASMA D(-)LACTATE LEVELS AFTER INTESTINAL ISCHEMIA-REPERFUSION INJURY
61 METABOLIC ACTIVITY OF PERIPHERAL RAT PHAGOCYTES DURING ISCHEMIA AND REPERFUSION OF SMALL INTESTINE
62 EXPRESSION OF C-FOS PROTEIN IN RAT BRAIN FOLLOWING OCCLUSION OF MESENTERIC ARTERY
63 THE CHANGES OF IgA IN INTESTINAL CONTENT OF RAT AFTER SCALD
64 AN EXPERIMENTAL STUDY OF BACTERIAL TRANSLOCATION PROMOTED BY INJURY TO INTESTINAL BARRIER AFTER SCALD
65 A STANDARDIZED AND CLINICAL RESEMBLE MODEL OF MULTIPLE ORGAN FAILURE
66 THE CLINICAL SIGNIFICANCE OF ENDOTOXIN RELEASE IN ELECTIVE COLORECTAL OPERATIONS IN REGARD TO ANTIBIOTIC PROPHYLAXIS
67 EFFECT OF KUPFFER CELL PHAGOCYTOSIS BLOCKADE INDUCED BY GdCL3 ON MOUSE ANAPHYLAXIS
68 ROLE OF KUPFFER CELLS IN ENDOTOXIN SENSITIVITY, TISSUE LOCALISATION OF ENDOTOXIN AND TNF PRODUCTION
69 EFFECTS OF ENDOTOXIN ON LIVER CELLS IN A LONG TERM IN VITRO SYSTEM
70 EFFECTS OF NITRIC OXIDE ON HEPATIC MICROCIRCULATION IN VIVO
71 HEPATIC PERFUSION AND VOLUME DURING ENDOTOXEMIA IN THE PIG
72 CYTOKINE RESPONSE TO LIVER RESECTION
73 MONITORING OF HEPATIC VENOUS OXYGEN SATURATION AFTER LIVER RESECTION
74 HYPOXIA OF THE GUT DURING ORTHOTOPIC LIVER TRANSPLANTATION
75 ANISODAMINE PROMOTES RECOVERY OF PORTAL FLOW AND pHi AFTER BURN INJURY
76 ENHANCEMENT OF INTESTINAL MOTILITY BY CISAPRIDE IN CRITICALLY ILL PATIENTS
77 INFLUENCE OF ENTEROSORPTION AND HYPSR-BAEIC OXYGENATION ON ESPATIC FUNCTION IN CHILDREN WITH SEPSIS
78 TRAUMATIC STRESS CAN CONSTRUCTIVELY PRECONDITION OR DESTRUCTIVELY PRIME CELLS PRIOR TO A SUBSEQUENT INSULT
79 ENDOTOXIN-INDUCED CHANGES IN MYOCYTE GENE EXPRESSION
80 PMN/MYOCYTE INTERACTIONS
81 DIRECT EFFECTS OF LPS ON MYOCARDIAL CELLS
82 CARDIODEPRESSANT FACTORS IN SHOCK-PROBLEMS IN COMPLETE CHARACTERIZATION OF IDENTIFIED PEPTIDES
83 EFFECTS OF CYTOKINES AND NO ON CARDIO-MYOCYTES
84 THE ROLE OF NITRIC OXIDE IN THE EARLY HEMODYNAMIC CHANGES IN HYPERDYNAMIC ENDOTOXEMIA
85 Changes in Cardiac Signal Transduction in Septic Shock
86 THE HEART IN SEPTIC SHOCK
87 N-ACETYL-L-CYSTEINE DEPRESSES CARDIAC PERFORMANCE IN PATIENTS WITH SEPTIC SHOCK
88 THE INCONSITENCY OF THE SLOPE OF THE END-SYSTOLIC PRESSURE-VOLUME RELATION AS A PARAMETER OF CONTRACTILITY IN MILD EXPERIMENTAL SEPSIS. COMPARISON THE RESULTS OF A COMPUTER MODEL STUDY WITH EXPERIMENT DATA
89 “PEAK SYSTOLIC PRESSURE/ENDSYTOLIC VOLUME RATIO” AND “END-SYSTOLIC PRESSURE-SEGMENTAL VOLUME RELATION” AS MEASURE OF LEFT VENTRICULAR FUNCTION IN SEPSIS
90 THE (n-3) FATTY ACID DOCOSAHEXAENOIC ACID DECREASES α1-ADRENOCEPTOR RESPONSIVENESS IN RAT CARDIOMYOCYTES
91 DERANGEMENT OF THE PHOSPHOINOSITIDE PATHWAY BY TNFα IN RAT CARDIOMYOCYTES
92 MITOCHONDRIAL DYSFUNCTION IS RELATED TO THE DECREASE OF PYRUVATE DEHYDROGENASE ACTIVITY IN SUBCHRONICALLY TNFα- AND IL 1α-EXPOSED NEONATAL RAT HEART CELLS
93 CONTRACTILITY AND CORONARY FLOW IN ISOLATED PERFUSED RABBIT HEARTS
94 S-NITROSOALBUMIN A POSSIBLE (PATHO-) PHYSIOLOGICAL CARRIER OF NO. HALF-LIFE AND EFFECT IN THE ISOLATED ERYTHROCYTE PERFUSED RABBIT HEART
95 NITRIC OXIDE PRODUCTION IN CARDIOMYOCYTES STIMULATED BY ENDOTOXIN AND CYTOKINES-SIGNIFICANCE FOR CONTRACTILE DEPRESSION
96 CARDIODEPRESSANT EFFECTS OF XENOREACTIVE NATURAL ANTIBODIES IN CARDIOMYOCYTES
97 REGULATION OF ELONGATION FACTOR 2 IN CARDIOMYOCYTES BY METABOLIC SIGNALS RELEVANT FOR SEPSIS AND SHOCK
98 HEMODYNAMIC CHANGES CAUSED BY TOURNIQUET ISCHEMIA AND REPERFUSION OF THE LEG IN AN ANIMAL MODEL
99 VALIDITY OF TRANSTHORACIC BIOIHREDANCE IN CARDIOCIRCULATORY FAILURE
100 EFFECTS OF ENDOTOXIN ON ISCHAEMIA-INDUCED ARRHYTHMIAS AND MYOCARDIAL INJURY IN RATS
101 THE IMPORTANCE OF LACTIC ACID, LACTATE AND PH-VALUE TO THE CONTRACTILE FORCE OF GUINEA PIG PAPILLARY MUSCLE COMPARED TO HEMODYNAMIC STATE IN PATIENTS WITH CIRCULATORY SHOCK
102 CARDIOGENIC PULMONARY EDEMA TREATED BY FACIAL MASK CPAP
103 ENHANCED NAD-REDUCTION IN SERUM OF PATIENTS WITH CARDIOGENIC SHOCK
104 MODS, MOF AND SIRS
105 SHOCK AND SEPSIS-INDUCED CELLULAR CHANGES
106 ANTI-TNF STRATEGIES IN SEPSIS
107 ASSESSMENT OF CELL-ASSOCIATED CYTOKINES FOLLOWING IN VITRO ENDOTOXIN STIMULATION, AND IN SEPTIC PATIENTS
108 FORMATION OF A TNF SYNTHESIS-INHIBITOR IN ENDOTOXIN TOLEFANCE
109 IN VIVO SHOCK PROTECTION OF rCD14
110 THE LPS-BINDING DOMAIN OF ENDOTOXIN NEUTRALISING PROTEINS
111 THE EFFECT OF LIPID PEROXIDATION ON HUMAN SECRETORY PHOSPHOLIPASE A2 (sPLA2)-MEDIATED DEGRADATION OF CELL MEMBRANES
112 MECHANISMS OF VASCULAR FAILURE RESULTING FROM SEPSIS AND ENDOTOXAEMIA
113 NITRIC OXIDE AND MULTIPLE ORGAN FAILURE
114 MOLECULAR CHARACTERIZATION OF THE HUMAN INDUCIBLE NITRIC OXIDE SYNTHASE GENE PROMOTER
115 REDUCED T-CELL IMMUNORESPONSIVENESS DURING POLYMICROBIAL SEPSIS IS ASSOCIATED WITH ELEVATED RATES OF APOPTOSIS IN THE T-HELPER CELL (CD4*) BUT NOT IN THE CYTOTOXIC T-CELL (CD8*) POPULATION
116 CYTOKINES AND THE MULTIPLE ORGAN DYSFUNCTION SYNDROME. A STUDY DURING ZY-MOSAN-INDUCED GENERALIZED INFLAMMATION IN MICE
117 THE NONIMMUNE DEFENSE SYSTEM OF PERITONEAL MACROPHAGES DURING THE DEVELOPMENT OF MULTIPLE ORGAN DYSFUNCTION SYNDROME IN MICE
118 UPOPOLYSACCHARIDE (LPS) BINDING CAPACITY OF WHOLE BLOOD FOLLOWING HAEMORRHAGE
119 CORRELATION BETWEEN REDUCED ENDOTOXIN PLASMA LEVELS AFTER REPEATED E. COLI CHALLENGE AND LBP/ACUTE PHASE RESPONSE IN BABOON
120 KINETICS OF ENDOTOXIN (LPS). CYTOKINE AND CYTOKINE MODULATORS IN A NON-HUMAN PRIMATE LPS MODEL
121 A ROLE FOR 13-HODD-ACYLATED PROTEINS IN CYTOKINE SYNTHESIS AND ENDOTOXIC SHOCK
122 SEVERE TRAUMA LEADS TO ENDOTOXIN TOLERANCE WITH DECREASED RELEASE OF PROINFLAMMATORY CYTOKINES
123 ENDOTOXIN MEDIATED ACTIVATION OF MONOCYTES AND NEUTROPHILS IN PLASMA AND EXUDATE IN SEVERE PERITONITIS DURING STAGED ABDOMINAL REPAIR (STAR)
124 COLORECTAL CANCER ENHANCES THE CYTOKINE RESPONSE TO SURGICAL TRAUMA
125 IS INTERLEUKINE-2 A SIGNIFICANT MEDIATOR OF RENAL FAILURE DURING SEPSIS SYNDROME?
126 ENDOTOXIN-INDUCED IMPAIRMENT OF RESPONSES TO SYMPATHETIC NERVE STIMULATION
127 PITUITARY-ADRENAL RESPONSE TO WAR WOUND
128 TOURNIQUET TRAUMA (TT) ON BETA-ADRENERGIC (B-AD) RECEPTORS AND CATECHOLAMINES (CA) IN THE SKELETAL MUSCLE OF THE RAT
129 BASIC FIBROBLAST GROWTH FACTOR (BFGF) IMMUNOREACTIVITY AS A POSSIBLE LINK BETWEEN HEAD INJURY AND ENHANCED OSTEOGENESIS
130 ROLE OF NEUTROPHIL IN COMPRESSION INJURY OF SPINAL CORD IN RATS
131 GENERAL RESPONSE OF ORGANISM AND OXIDATIVE STRESS IN THE BRAIN AFTER CONCOMITANT CEREBRAL AND PERIPHERAL TRAUMA
132 INFLAMMATORY AND ANTI-INFLAMMATORY RESPONSE AFTER NEUROSURGERY
133 SHOCK COMPLICATING SEVERE FALCIPARUM MALARIA
134 CYTOKINE STIMULATION AND MITOGENESIS PRODUCED BY SECRETED PRODUCTS OF VIRIDANS STREPTOCOCCI RESPONSIBLE FOR THE VIRIDANS SHOCK SYNDROME
135 POSTOPERATIVE ORGAN FAILURE IN CANCER PATIENTS IS NOT DUE TO DEFICIENT PLASMA PROTEASE INHIBITORS
136 INTRAPERITONEAL INFLAMMATION - ROLE OF CYTOKINES AND PROTEINASES IN ASCITES FORMATION
137 VENOARTERIAL CO2 TENSION GRADIENT (DPCO2) AND SIGNIFICANCE OF HALDANE EFFECT IN SEPSIS AND SHOCK
138 MAIN CORRELATES OF CHOLESTEROLEMIA IN SURGICAL TRAUMA, SEPSIS AND SHOCK
139 TAURINE METABOLISM IN SEPSIS
140 ANTIOXIDATIVE DEFENSE IN THE RAT SKIN TISSUE AFTER THERMAL INJURY
141 OXYGEN TENSION EFFECT ON THE PRODUCTION OF REACTIVE OXYGEN SPECIES BY HUMAN PHAGOCYTES IN VITRO
142 CHANGES AND MECHANISM OF POLYMORPHONUCLEAR ADHESION AFTER BURN INJURY
143 CYTOKINE PRODUCTION IN THERMAL INJURY
144 THERMAL TRAUMA-INDUCED CHANGES IN THE RAT LIVER GLUCOCORTICOID RECEPTOR CHARACTERISTICS
145 THE INFLUENCE OF “SUPRANORMAL” HEMODY-NAMIC VALUES ON THE MORTALITY OF SEVERELY BURNED PATIENTS
146 MUSCLE PO2 AND ESTIMATION OF MUSCLE OXYGEN CONSUMPTION IN PATIENTS WITH SEPSIS
147 IMMUNOLOGICAL MONITORING OF NEW INFLAMMATORY PARAMETERS IN SEPSIS AND TRAUMA PATIENTS
148 HIGH SOLUBLE TNF RECEPTOR P55 LEVELS EARLY PREDICT OUTCOME IN SCORE-IDENTIFIED POST-CARDIAC SURGICAL PATIENTS AT HIGH RISK FOR SEPSIS
149 LPS TOXICITY REGULATING PROTEINS IN BACTEREMIA
150 RAPID DETECTION OF BACTEREMIA IN
151 SCORING SYSTEMS IN PATIENTS WITH PERITONITIS AND SEPSIS
152 PLASMA LEVELS OF GLUTATHIONE, α-TOCOPHEROL AND LIPID PEROXIDES IN POLYTRAUMATIZED PATIENTS
153 THE ANTIOXIDATIVE GLUTATHIONE SYSTEM IN POLYTRAUMATIZED PATIENTS - IS THESE CORRELATION WITH SEVERITY OF INJURY?
154 INVESTIGATION OF PHAGOCYTE ACTIVATION BY CHEMILUMINESCENCE FOLLOWING TRAUMA SURGERY
155 POLYMORPHONUCLEAR NEUTROPHILS (PMN) FUNCTIONAL ALTERATIONS AFTER ANESTHESIA AND SURGERY IS THERE RELATIONSHIP WITH POSTOPERATIVE SEPSIS
156 IS NEUTROPHIL MIGRATION A RELIABLE MARKER FOR THE COURSE CONTROL OF WOUND HEALING FOLLOWING TRAUMA SURGERY?
157 IMPLICATION OF PHAGOCYTOSIS AND LIPED PEROXIDATION IN MONITORING OF UNEVENTFUL WOUND HEALING FOLLOWING TRAUMA SURGERY
158 EXPRESSION OF POLYMORPHONUCLEAR NEUTROPHIL ADHESION MOLECULE CD11b/CD18 AND IL-8 PRODUCTION DURING NORMOTHERMIC CARDIOPULMONARY BYPASS
159 CITRATE SYNTHASE AS A MARKER OF EARLY MYOCARDIAL NECROSIS DETERMINED BY MONOCLONAL ANTIBODIES
160 CHANGES OF CITRATE SYNTHASE ENZYME ACTIVITY COMPARED WITH CREATINE KINASE FOLLOWING HEART ISCHEMIA
161 PATTERN-SPECIFIC RELEASE OF PROSTANOIDS IN POLYTRAUMATIZED PATIENTS
162 COMPOUND FRACTURES IN POLYTRAUMATIZED PATIENTS - IS THERE AN INFLUENCE ON PLASMA LEVELS OF ENDOTOXIN, TNFα, OR IL-6?
163 Early and high SIL-6 concentrations in patients with thoracic trauma and polytrauma
164 PLASMA ILI, TNF AND IL6 ACTIVITIES AFTER WAR WOUNDS
165 THE RELATIONSHIP BETWEEN SERUM ENZYMES AND THE INJURY SEVERITY IN WAR CASUALTIES
166 TYPE II PHOSPHOLIPASE A2 LEVELS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (AMI)
167 PROGNOSTIC VALUE OF PLASMA TYPE II PHOSPHOLIPASE A2 ACTIVITY IN SEPTIC SHOCK
168 PLASMA CHOLESTEROL IN SEPSIS AND SHOCK
169 NORMOTHERMIC CARDIOPULMONARY BYPASS AND CYTOKINE RELEASE
170 IL-10, IL-4 AND IL-1RA LEVELS IN PATIENTS WITH SEPTIC SHOCK
171 BLOOD CYTOKINE AND COMPLEMENT LEVELS IN PATIENTS WITH SEPSIS
172 ANAPHYLATOXIN
173 BENEFITS FOR THE SURGICAL INTENSIVE CARE PATIENT FROM A COMPUTER HANDLING SYSTEM FOR PROTEASE ACTIVITY DATA
174 ASSESSMENT OF EARLY C5a GENERATION DURING CARDIOPULMONARY BYPASS IN PIG
175 DETECTION OF ANASTOMOTIC LEAKS AFTER COLORECTAL SURGERY BY MEASURING LPS IN THE DRAINAGE FLUID
176 CYTOKINE LEVELS IN PATIENTS WITH SEVERE BURN INJURY
177 PLASMA LEVELS OF ENDOTHELIN-1 AND THROMBOMODULIN IN PATIENTS WITH BURNS
178 ENDOTOXEMIA AND BACTEREMIA IN SEPSIS SYNDROME
179 INFECTION MONITORING AND-THERAPY POST TRAUMA-A RATIONAL CONCEPT
180 EVALUATION OF SOLUBLE E-SELECTIN UNDER SEPTIC AND POST-TRAUMATIC CONDITIONS - EXPERIMENTAL AND CLINICAL STUDIES
181 PLASMA LEVELS OF SOLUBLE E-SELECTIN IN PATIENTS WITH DISSEMINATED INTRA-VASCULAR COAGULATION (DIC)
182 PROCALCITONIN IN SEPTIC SHOCK
183 Procalcitonin Concentrations in Pleural Effusion as a Marker of Human Septic Response
184 PAF ACETYLHYDROLASE AND ARACHIDONIC ACID METABOLITE LEVELS IN PATIENTS WITH SEPSIS
185 HIGH PREOPERATIVE CRP LEVELS INDICATE AN INCREASED RISK OF SIGNIFICANT POSTOPERATIVE COMPLICATIONS
186 PROGNOSIS OF POSTOPERATIVE INFECTIOUS COMPLICATIONS IN PATIENTS WITH ESOPHA-GEAL CANCER
187 ACUTE PANCREATITIS - AN INTEGRATED APPROACH TO DIAGNOSIS AND TREATMENT
188 IMMUNOLOGICAL PROBLEMS IN EMERGENCY SURGERY AND TRAUMATREATMENT
189 VALIDITY OF ICP-MONTTORING IN PATIENTS WITH SEVERE HEAD INJURY
190 THE VALUE OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN THE DIAGNOSIS OF TRAUMATIC RUPTURE OF THE THORACIC AORTA
191 Consensus development in guide-lines for sepsis treatment
192 RISK PREDICTION IN RECENT CLINICAL TRIALS IN SEPSIS/SIRS
194 NON-ANTICOAGULANT HEPARINOID AND THE ACUTE LUNG INJURY ASSOCIATED WITH SMOKE
195 RESULTS OF A MULTI-CENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CP-0127, A NOVEL BRADYKININ ANTAGONIST. IN PATIENTS WITH SIRS AND SEPSIS
196 B1 KININ RECEPTOR ACTIVITY IS ASSOCIATED WITH PRE-EXISTING INFLAMMATION IN PIGS
197 EFFECT OF COMBINED B1 AND B2 KININ RECEPTOR BLOCKADE IN PORCINE LPS SHOCK
198 DEXTRAN SULFATE ACTIVATES THE CONTACT SYSTEM AND MEDIATES ARTERIAL HYPOTENSION VIA B2 KININ RECEPTORS
199 NITRIC OXIDE IN SEPSIS
200 SELECTED TREATMENT STRATEGIES FOR SEPTIC SHOCK BASED ON PROPOSED MECHANISMS OF PATHOGENESIS
201 ANTICYTOKINE THERAPIES IN SEPTIC SHOCK
202 THE NEUTROPHIL AS A THERAPEUTIC TARGET IN SEPTIC SHOCK
203 SAFETY AND EFFICACY OF THE MONOCLONAL ANTI-TNF ANTIBODY-FRAGMENT MAK 195F IN PATIENTS WITH SEPSIS AND SEPTIC SHOCK
204 THE EFFECT OF RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST ON ORGAN DYSFUNCTION AND SURVIVAL IN POSTOPERATIVE SURGICAL PATIENTS WITH SEPSIS SYNDROME
205 THE ANTI-INFLAMMATORY EFFECT OF G-CSF TREATMENT OF VOLUNTEERS ON BLOOD CYTOKINE RESPONSE
206 RECOMBINANT HIRUDIN INHIBITS TISSUE FACTOR INDUCED DISSEMINATED INTRA-VASCULAR COAGULATION IN RABBITS
207 STRUCTURE-BASED DRUG DESIGN OF INHIBITORS OF HUMAN NONPANCREATIC SECRETORY PHOSPHOLIPASE A
208 EFFECTS OF NG-METHYL-ARGININE IN CLINICAL SHOCK
209 CONFIRMING PHASE III CLINICAL TRIAL TO STUDY THE EFFICACY OF A P.A.F. ANTAGONIST, BN 52021 [BN], IN REDUCING MORTALITY OF PTS WITH SEVERE GRAM-NEGATIVE SEPSIS [GNS],
210 TREATMENT OF SEPSIS - ROLE OF MULTIPLE COMPONENT THERAPY
211 COMBINED IMMUNOTHERAPY IN THE TREATMENT OF SEPTIC SHOCK
212 IMMUNOMODULATORY APPROACHES IN CRITICALLY ILL SURGICAL PATIENTS
213 NEW THERAPEUTICAL APPROACHES IN THE THERAPY OF PATIENTS WITH SEVERE SEPSIS - THE ROLE OF ANTI-INFLAMMATORY MEDIATORS
214 GLUTAMTNE INFLUENCES PHENOTYPE AND FUNCTION OF MONOCYTES FROM HEALTHY INDIVIDUALS AND FROM SEPTIC PATIENTS
215 Treatment of Septic Shock with Gene Transfer
216 INFLUENCE OF THE SINGLE INFUSION OP THE HEW HXPEROSMOLAR SOLUTION “SORBI-LACT” OB THE RECOVERY OF MOBILITY IN DIFFERENT PARTS Of GASTROINTESTINAL TRACT (GIT) OF DOGS IN EARLY POSTOPERATIVE PERIOD
217 PLASMAPHERESIS AS RESCUE THERAPY IN SEVERE SEPTIC SHOCK
218 CONTINUOUS HEMOFILTRATION AND HEMO-DIAFILTRATION IN SEPSIS-INDUCED MULTIPLE ORGAN DYSFUCTION
219 HEMODYNAMIC EFFECTS BY ELIMINATION OF CIRCULATORY ENDOTOXIN
220 A MICROSPHERE BASED DETOXIFICATION SYSTEM (MDS) - AN EFFECTIVE WAY FOR CONTINUOUS ELIMINATION OF ENDOTOXINS AND MEDIATORS
221 DOSE-RESPONSE OF E5531, A LIPID A ANTAGONIST, IN THE SUPPRESSION OF RESPONSE TO ENDOTOXIN IN NORMAL VOLUNTEERS
222 MECHANISM OF BENEFICIAL EFFECTS OF SYNDETOXIN ON PHAGOCYTES IN BACTERIAL INFECTIONS
223 IN VITRO AND IN VIVO NEUTRALIZATION OF LPS BY HUMAN POLYSPECIFIC IgM
224 DIFFERENCES IN THE SERUM IMMUNOGLOBULIN KINETICS AFTER SURGICAL TRAUMA OF VARYING SEVERITY
225 TNF ANTIBODY TREATMENT REDUCES THE PRODUCTION OF ACTIVE TGF-B1, BUT NOT OF IL-10 IN A BABOON SEPSIS MODEL
226 PRETREATMENT WITH INTERLEUKIN-10 (IL-10) DOWNREGULATES THE INCREASED RELEASE OF PROINFLAMMATORY CYTOKINES IN EXPERIMENTAL ENDOTOXEMIA
227 THYMOCARTIN DOWN-REGULATES TNFα PRODUCTION AND PREVENTS THE CONSEQUENCES OF ENDOTOXIN SHOCK
228 PC-PLC INHIBITOR D609 ATTENUATES INFLAMMATORY RESPONSE AND INCREASES SURVIVAL IN MOUSE ENDOTOXIN SHOCK
229 EFFECTS OF CONTINUOUS INFUSION OF METHYLPREDONISOLE ON PATIENTS WITH HYPERCYTOKINEMIA
230 GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR (GM-CSF) IN EXPERIMENTAL PERITONITIS
231 EFFECTS OF NG-MONOMETHYL-L-ARGININE (L-NMMA) ON HEMODYNAMICS AND MORTALITY IN R-VTS FOLLOWING HEMORRHAGIC SHOCK
232 THE EFFECT OF NG-NITRO-L-ARGININE-METHYL-ESTER (L-NAME) ON THE HEMORRHAGIC HYPOVOLEMIA IN ANAESTHETIZED RABBITS
233 NON-ARGININE BASED, SELECTIVE INHIBITORS OF INDUCIBLE NO SYNTHASE EXERT BENEFICIAL EFFECTS IN ENDOTOXIC SHOCK
234 A NEW NON-AMINO ACID INHIBITOR OF NITRIC OXIDE SYNTHASE (3936W92) IN HYPERDYNAMIC OVINE SEPSIS
235 THE EFFECTS OF NG-NITRO L-ARGININE METHYL ESTER (L-NAME) ON ACID-BASE STATUS IN ARTERIAL AND VENOUS BLOOD IN HEMORRHAGIC SHOCK
236 BENEFICIAL EFFECTS OF LIPOXYGENASE AND CYCLOOXYGENASE INHIBITORS ON VESSELS REACTION IN ENDOTOXIC SHOCK
237 EFFECTS OF SOME LIPOXYGENASE AND CYCLOOXYGENASE INHIBITORS ON THE CHEMILUMINESCENCE OF PHAGOCYTES
238 PROTECTIVE EFFECT OF DICLOFENAC SODIUM AGAINST POST TRAUMATIC INFECTION AND SEPTIC SHOCK
239 PHARMACOLOGICAL INTERVENTION IN THE EXPERIMENTAL ENDOTOXIN SHOCK
240 HI-ANTAGONISTS IMPROVE CARDIAC FUNCTION AND MICROCIRCULATION IN PORCINE ENDOTOXIC SHOCK
241 ANTI-INFLAMMATORY EFFECT OF BETA 2 AGONIST ON HEPATIC ENDOTHELTUM IN PORCINE PERITONITIS
242 ANTIPHLOGISTIC THERAPY BY PHARMACOLOGICAL MANIPULATION OF THE COMPLEMENT SYSTEM
243 ORGAN DAMAGE AND ANTIOXIDANT PROTECTION IN THE SEPTIC SHOCK
244 EFFECTS OF A NEW LIPID PEROXIDATION INHIBITOR U-74389G IN A SHEEP MODEL OF MULTIPLE ORGAN FAILURE
245 GLYCERYL TRINITRATE, NEUTROPHIL ELASTASE AND IL8 DURING CARDIOPULMONARY BYPASS
246 CREATINE PHOSPHATE DID NOT PROTECT TISSUE AGAINST PHAGOCYTE MOBILIZATION DURING OPEN HEART SURGERY
247 GABEXATE MESILATE, A SYNTHETIC ANTICOAGULANT, ATTENUATES ENDO-TOXIN-INDUCED PULMONARY VASCULAR INJURY BY INHIBITING ACTIVATED LEUKOCYTES
248 EFFECT S OF TEMPERATURE ON THE ANTICOAGULATIVE ACTIVITY OF HEPARIN AN IN-VITRO STUDY
249 ATTENUATION OF HEMORRHAGIC SHOCK-INDUCED GASTRIC MUCOSAL LESION BY ANTITHROMBIN III IN RATS
250 ATTENUATION OF ENDOTOXIN-INDUCED PULMONARY VASCULAR INJURY BY ANTITHROMBIN III
251 FIRST RESULTS OF A PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL WITH ANTITHROMBIN III (AT III) INTRAVENOUSLY AND FRESH FROZEN SERUM INTRAPERITONEALLY AS ADJUVANT THERAPY IN PATIENTS WITH DIFFUSE SECONDARY PERITONITIS
252 SEQUENTIAL LEVELS OF PMN-ELASTASE DURING SEPTIC SHOCK. EFFECTS OF TREATMENT WITH ANTITHROMBIN III (ATIII) OR HA-1A
253 NON-STEROID MODULATION OF GLUCOCORTICO-ID RECEPTORS FUNCTION BY MORPHINE DERI-VATES IN SHOCK
254 COMPARATIVE ANALYSIS OF THE EPPICIEHCY OP THE TREATMENT IN POLYTHAUHATIZED PATIENTS IK PHEHOSPUA1 EMERGENCY CARE
255 Iron-induced lipid peroxidation in whole blood in vitro as determined by malondialdehyde and luminol-enhanced chemiluminescence - implications for iron supplimentation to iron-depleted patients
AUTHOR-ABSTRACT INDEX